Desk›Healthcare› Sandu Pharmaceuticals Ltd
Sandu Pharmaceuticals Ltd
BSE 524703 · NSE SANDUPHQ · ISIN INE751D01014 · Group X · Active
Healthcare › Healthcare › Pharmaceuticals & Biotechnology › Pharmaceuticals
₹37.08
-0.35%
BSE close, 28 August 2026
₹35.82 cr
1.0 cr shares · Micro cap
₹21.71 cr
as published
20.3× · 0.88×
EPS ₹1.83 · BV ₹42.14
69.94 / 1.77
₹ cr, as filed
23
3 selected · 13%
Reg 30
Sch. III Part A
Price 52-week, BSE
| Against 52-week high | -26.6% |
|---|---|
| Against 52-week low | +23.6% |
| Day change | -0.35% |
| Size band | Micro cap |
| Index membership | None |
Valuation as published by BSE
| Earnings per share | ₹1.83 |
|---|---|
| Price / earnings | 20.26× |
| Price / book | 0.88× |
| Book value — derived, price ÷ P/B | ₹42.14 |
| Return on equity | 4.33% |
| Operating margin | 3.39% |
| Net margin | 1.39% |
Consistency check
- P/B ÷ P/E, which must equal ROE
- 4.34%
- ROE as published
- 4.33%
Results ₹ crore, as filed
RevenueNet profit one scale across all three periods, ₹ crore
| Period | Revenue ₹cr | Net profit ₹cr | EPS ₹ | OPM | NPM |
|---|---|---|---|---|---|
| Jun-26 · Q | 16.39 | 0.23 | 0.37 | 3.39% | 1.39% |
| Mar-26 · Q | 16.85 | 0.04 | 0.04 | 5.57% | 0.26% |
| FY25-26 | 69.94 | 1.77 | 1.83 | 4.92% | 2.53% |
Quarter on quarter
- Revenue, quarter on quarter
- -2.7%
- Net profit, quarter on quarter
- +475.0%
- Operating margin, quarter on quarter
- -218 bps
Disclosure profile 23 filings in the window
| Tag | Filings |
|---|---|
| Selected | |
| Board Outcome | 1 |
| Change in Management | 1 |
| Results | 1 |
| Selected sub-total | 3 |
| Procedural | |
| General | 7 |
| Newspaper Publication | 4 |
| AGM / EGM | 2 |
| Annual Report | 1 |
| Board Meeting | 1 |
| Book Closure | 1 |
| Compliance Certificate | 1 |
| Other Update | 1 |
| Record Date | 1 |
| Trading Window | 1 |
| Procedural sub-total | 20 |
| Total | 23 |
Disclosure regime
LODR Reg 30
Read with Schedule III Part A. An equity filer in BSE Group X, so the Regulation 30 disclosure framework and the Schedule III event list both apply.
Filing rhythm · 93 trading days
23 filings · 3 selected · busiest 2026-08-11
Filing rhythm · the twelve most recent
2026-08-132026-10-09
SelectedProcedural
Filings
23 in the window · 7 earlier on record
-
9 October 2026 ·
Intimation Regarding Change In Name Of Director From Dr Neeti Madan Kapre To Dr Neeti Gupta.
Intimation about change in name of Director from Dr Neeti Madan Kapre to Dr Neeti Gupta
Company Update / General View filing →
-
8 October 2026 ·
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
compliance certificate under Reg 74(5) of SEBI(DP) Regulation for Q ended 30th September 2026
Company Update / Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018 View filing →
-
30 September 2026 ·
Intimation To The Holders Of Physical Securities To Furnish PAN And KYC Details
Intimation to the holders of Physical Securities to furnish PAN and KYC details
Company Update / General View filing →
-
22 September 2026 ·
Closure of Trading Window
Intimation about closure of trading window for Quarter ended 30th September 2026
Insider Trading / SAST / Closure of Trading Window View filing →
-
11 September 2026 ·
Shareholder Meeting / Postal Ballot-Outcome of AGM
Proceedings of the 41st Annual General Meeting held on Friday 11th september 2026 at 04:30 pm
AGM/EGM / AGM View filing →
-
4 September 2026 ·
Newspaper Publication
Newspaper Publication opening of special window for re-lodgement of transfer request for physical shares
Company Update / Newspaper Publication View filing →
-
20 August 2026 ·
Newspaper Publication
Newspaper Advertisement intimating shareholders about Notice of Annual General Meeting and Evoting
Company Update / Newspaper Publication View filing →
-
19 August 2026 ·
Announcement Under Regulation 30-Letter To Shareholder On Annual Report Weblink Whose Email Ids Are Not Registered With The Company/RTA
Letters to shareholders on annual report weblink whose email ids are not registered with the company/RTA
Company Update / General View filing →
-
19 August 2026 ·
Reg. 34 (1) Annual Report.
41st Annual Report of Sandu Pharmaceuticals Limited
Others / Reg. 34 (1) Annual Report View filing →
-
19 August 2026 ·
Annual General Meeting To Be Held On 11Th September 2026 At 04:30 Pm Through Video Conferencing ('VC')/ Other Audio Visual Means (QAVM)
Intimation about Annual General Meeting
AGM/EGM / AGM View filing →
-
14 August 2026 ·
Newspaper Publication
Newspaper Advertisement Pre despatch of Annual Report intimation to Shareholders
Company Update / Newspaper Publication View filing →
-
13 August 2026 ·
Newspaper Publication
Newspaper Publication Unaudited Financials for Q ended 30th June 2026
Company Update / Newspaper Publication View filing →
-
11 August 2026 ·
Approval Of Material Related Party Transactions Subject To Approval Of Shareholders
approval of material related party transactions subject to approval of shareholder
Company Update / General View filing →
-
11 August 2026 ·
Statement Of Deviation And Utilisation Of Funds For Q Ended 30.06.2026
statement of deviation and utlisation of funds for q ended 30.06.2026
Company Update / Reg. 32 (1), (3) - Statement of Deviation & Variation View filing →
-
11 August 2026 ·
Change in Management
Appointment of M/s Dave & Dave Chartered Accountant as statutory auditor subject to approval of the shareholder
Company Update / Change in Management View filing →
-
11 August 2026 ·
Intimation About The Date Of The Annual General Meeting
Intimation about the date of the annual General Meeting
Company Update / General View filing →
-
11 August 2026 ·
Intimation About The Record Date
Intimation about the Record date
Corp. Action / Record Date View filing →
-
11 August 2026 ·
Intimation About Book Closure For AGM
Intimation about Book closure for AGM
Corp. Action / Book Closure View filing →
-
11 August 2026 ·
Outcome And Results Of The Board Meeting Dated 11.08.2026 Was Submitted On Time But Inadvertently No Digital Signature Was Affixed On The Covering Letter Further There Is No Change In The Contents Of The Outcome
Outcome and results of the Board Meeting dated 11.08.2026
Company Update / General View filing →
-
11 August 2026 ·
Unaudited Financials For Q Ended 30.06.2026
Unaudited Financials For ended 30.06.2026
Result / Financial Results View filing →
-
11 August 2026 ·
Outcome Of The Board Meeting
Outcome of the Board Meeting 11.08.2026
Company Update / General View filing →
-
11 August 2026 ·
Board Meeting Outcome for Outcome Of The Board Meeting Dated 11.08.2026
Outcome of the Board Meeting
Board Meeting / Outcome of Board Meeting View filing →
-
3 August 2026 ·
Board Meeting Intimation for To Consider And Approve The Standalone Unaudited Financial Results Of The Company For The Quarter Ended 30Th June, 2026.
Sandu Pharmaceuticals Ltd has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 11/08/2026 ,inter alia, to consider and approve 1.To consider and approve ....
Board Meeting / Board Meeting View filing →
RSS feed for Sandu Pharmaceuticals Ltd · the 50 most recent filings